This article is more than 5 years old. Information may no longer be current.
Top stories in cardiology: Recall involving intra-ortic balloon pumps, icosapent ethyl reduces CV events
Click Here to Manage Email Alerts
Among the top stories in cardiology this week was an FDA recall of intra-aortic balloon pumps and a report that explained how icosapent ethyl improved outcomes in adults with elevated CV risk that are treated with statins.
Other top stories included a study that concluded height could be a factor in developing varicose veins, a report that suggested the importance of physical activity in achieving good CV health and a presentation that indicated how cardiologists can use social media to their advantage. – by Janel Miller
Intra-aortic balloon pumps recalled due to malfunctions at high altitudes
The FDA announced that Getinge issued a voluntary recall of two intra-aortic balloon pumps due to interruption or inability to start therapy at high altitudes. Read more.
REDUCE-IT topline results announced: Icosapent ethyl reduces CV events
Amarin announced today topline results from the REDUCE-IT CV outcomes trial showing that the trial met its primary endpoint demonstrating approximately 25% RR reduction in major adverse CV events in the intent-to-treat population with use of icosapent ethyl compared with placebo. Read more.
Height may predict risk for varicose veins
Genes that determine height may also play a role in the formation of varicose veins, with taller people at greater risk for developing the condition, according to a study published in Circulation. Read more.
Physical inactivity major risk factor for mortality, CVD
Physical activity contributes to cardiorespiratory health and reduced risk for CVD, making physical inactivity one of the leading modifiable risk factors, according to a review published in the Journal of the American College of Cardiology. Read more.
Social media helps cardiologists learn, build personal brand
Cardiologists benefit from engaging in social media because it helps them learn and build personal brands, according to presentations at the European Society of Cardiology Congress. Read more.